COMMUNIQUÉS West-GlobeNewswire
-
Circle Health Launches as Toronto's First Longevity-Focused Primary Care Practice
19/11/2026 -
Lisata Therapeutics, Inc. Announces Reverse Stock Split Effective November 23, 2026
19/11/2026 -
InSitu Biologics Announces Completion of INSB200™ GMP Manufacturing Batch
19/11/2026 -
Koç Healthcare Calls for Clearer Travel Insurance Cover at ITIC Global 2026 and Highlights New Ground Ambulance Services
19/11/2026 -
NEXGEL Postpones Third Quarter 2026 Financial Results and Corporate Update Conference Call to November 24th
19/11/2026 -
Cingulate Announces U.S. Patent Issuance for CTx-2103, Further Validating PTR™ Technology Platform
19/11/2026 -
Acentra Health CEO Todd Stottlemyer Named 2026 Virginia Business Icon Honoree
19/11/2026 -
Hennick Humber Hospital Foundation’s Big Bash for Humber Raises $3.9 Million NET to Bring Life-Saving Cardiac Care Closer to Home
19/11/2026 -
The Silk Road Gets a Spidey Genetic Upgrade
19/11/2026 -
Sienna Senior Living Introduces Virtual Primary Care Benefit for Employees and Their Families
19/11/2026 -
Researchify Health Announces Five-Year Plan to Engage 100 Million Patients Each Month About Clinical Trials
19/11/2026 -
GATC Health Joins Bipartisan Panel at U.S. Capitol on the Future of Human-Relevant Drug Development
19/11/2026 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
19/11/2026 -
Regeneron Highlights New Data Across Malignant and Classical Hematology Programs at American Society of Hematology (ASH)
19/11/2026 -
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the Connective Tissue Oncology Society (CTOS) 2026 Annual Meeting
19/11/2026 -
Remix Therapeutics Announces Updated Positive REM-422 Phase 1 Data in Adenoid Cystic Carcinoma at 2026 EORTC-NCI-AACR Symposium
19/11/2026 -
Korro to Participate in Upcoming Investor Conferences
19/11/2026 -
Adagene Announces First Patient Dosed in Phase 1 Study of ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
19/11/2026 -
Evaxion announces strategy and business update and third quarter 2026 financial results
19/11/2026
Pages